SELLAS Life Sciences Group, Inc. (SLS) stock
SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$19.15+11.68 (+156.36%)
Close on Nov 17, 2026Market cap $3.87BP/E –Yield –
SELLAS Life Sciences total assets
Total assets on the balance sheet at the end of each period.
SELLAS Life Sciences's total assets was $145.38M at Jun 30, 2026. For fiscal 2025 it was $78.35M, up 303.2% from the year before. Over ten years it grew -0.5% a year on average. The highest annual figure on record is $87.98M in fiscal 2013.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.35M | +303.2% |
| FY2024 | Dec 31, 2024 | $19.43M | +212.5% |
| FY2023 | Dec 31, 2023 | $6.22M | -70.3% |
| FY2022 | Dec 31, 2022 | $20.94M | -20.3% |
| FY2021 | Dec 31, 2021 | $26.28M | -42.9% |
| FY2020 | Dec 31, 2020 | $46.05M | +177.3% |
| FY2019 | Dec 31, 2019 | $16.61M | -1.8% |
| FY2018 | Dec 31, 2018 | $16.92M | -49.5% |
| FY2017 | Dec 31, 2017 | $33.53M | +422.2% |
| FY2016 | Dec 31, 2016 | $6.42M | -92.2% |
| FY2015 | Dec 31, 2015 | $82.14M | +2.1% |
| FY2014 | Dec 31, 2014 | $80.49M | -8.5% |
| FY2013 | Dec 31, 2013 | $87.98M | +60.0% |
| FY2012 | Dec 31, 2012 | $54.99M | +77.6% |
| FY2011 | Dec 31, 2011 | $30.97M | +314.2% |
| FY2010 | Dec 31, 2010 | $7.48M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $145.38M | +350.0% |
| Q1 FY2026 | Mar 31, 2026 | $114.18M | +226.6% |
| Q4 FY2025 | Dec 31, 2025 | $78.35M | +303.2% |
| Q3 FY2025 | Sep 30, 2025 | $51.56M | +94.5% |
| Q2 FY2025 | Jun 30, 2025 | $32.31M | +113.7% |
| Q1 FY2025 | Mar 31, 2025 | $34.96M | +43.1% |
| Q4 FY2024 | Dec 31, 2024 | $19.43M | +212.5% |
| Q3 FY2024 | Sep 30, 2024 | $26.51M | +227.8% |
| Q2 FY2024 | Jun 30, 2024 | $15.12M | -18.6% |
| Q1 FY2024 | Mar 31, 2024 | $24.43M | -16.0% |
| Q4 FY2023 | Dec 31, 2023 | $6.22M | -70.3% |
| Q3 FY2023 | Sep 30, 2023 | $8.09M | -68.9% |
| Q2 FY2023 | Jun 30, 2023 | $18.57M | -42.4% |
| Q1 FY2023 | Mar 31, 2023 | $29.10M | +35.8% |
| Q4 FY2022 | Dec 31, 2022 | $20.94M | -20.3% |
| Q3 FY2022 | Sep 30, 2022 | $26.00M | -31.5% |
| Q2 FY2022 | Jun 30, 2022 | $32.21M | -26.2% |
| Q1 FY2022 | Mar 31, 2022 | $21.43M | -47.2% |
| Q4 FY2021 | Dec 31, 2021 | $26.28M | -42.9% |
| Q3 FY2021 | Sep 30, 2021 | $37.95M | +105.0% |
| Q2 FY2021 | Jun 30, 2021 | $43.62M | +200.6% |
| Q1 FY2021 | Mar 31, 2021 | $40.58M | +138.3% |
| Q4 FY2020 | Dec 31, 2020 | $46.05M | +177.3% |
| Q3 FY2020 | Sep 30, 2020 | $18.51M | -13.8% |
| Q2 FY2020 | Jun 30, 2020 | $14.51M | -42.0% |
| Q1 FY2020 | Mar 31, 2020 | $17.03M | +14.1% |
| Q4 FY2019 | Dec 31, 2019 | $16.61M | -1.8% |
| Q3 FY2019 | Sep 30, 2019 | $21.48M | -44.2% |
| Q2 FY2019 | Jun 30, 2019 | $25.03M | -21.7% |
| Q1 FY2019 | Mar 31, 2019 | $14.93M | -55.4% |
| Q4 FY2018 | Dec 31, 2018 | $16.92M | -49.5% |
| Q3 FY2018 | Sep 30, 2018 | $38.47M | -22.4% |
| Q2 FY2018 | Jun 30, 2018 | $31.97M | -47.2% |
| Q1 FY2018 | Mar 31, 2018 | $33.49M | -52.4% |
| Q4 FY2017 | Dec 31, 2017 | $33.53M | +422.2% |
| Q3 FY2017 | Sep 30, 2017 | $49.60M | -31.9% |
| Q2 FY2017 | Jun 30, 2017 | $60.55M | – |
| Q1 FY2017 | Mar 31, 2017 | $70.33M | – |
| Q4 FY2016 | Dec 31, 2016 | $6.42M | – |
| Q3 FY2016 | Sep 30, 2016 | $72.85M | – |
See a number that looks wrong?